Clinical Trials

Sotrastaurin in psoriasis

A 2-week multiple ascending dose, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of oral AEB071, a protein kinase C inhibitor, in moderate to severe psoriasis patients

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here